NO20091954L - Anvendelse av ostradiolvalerat eller 17ß-ostradil i kombinasjon med dienogest for oral terapi for opprettholdelse og/eller okning av kvinnelig libido - Google Patents
Anvendelse av ostradiolvalerat eller 17ß-ostradil i kombinasjon med dienogest for oral terapi for opprettholdelse og/eller okning av kvinnelig libidoInfo
- Publication number
- NO20091954L NO20091954L NO20091954A NO20091954A NO20091954L NO 20091954 L NO20091954 L NO 20091954L NO 20091954 A NO20091954 A NO 20091954A NO 20091954 A NO20091954 A NO 20091954A NO 20091954 L NO20091954 L NO 20091954L
- Authority
- NO
- Norway
- Prior art keywords
- combination
- dienogest
- maintain
- valerate
- ostradil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Oppfinnelsen angår anvendelse av østradiolvalerat eller østradiol i kombinasjon med 17(a-cyanometyl-17b-hydroksyøstra-4,9-dien-3-on (dienogest) i et multifase- eller enkeltfase-kombinasjonspreparat for oral terapi for opprettholdelse av og/eller økning av kvinnelig libido, eventuelt også forenet med oral prevensjon. De totale daglige doseenheter av multifase-kombinasjonen og av den farmasøytisk akseptable placebo eller enkeltfase-kombinasjonen og de aktiv bestanddelfrie og placebofrie daglige doseenheter svarer til 28 dager.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06022091 | 2006-10-20 | ||
EP07009373A EP1930010A1 (de) | 2006-10-20 | 2007-05-10 | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
PCT/EP2007/008866 WO2008046559A1 (de) | 2006-10-20 | 2007-10-12 | VERWENDUNG VON ESTRADIOLVALERAT ODER 17ß-ESTRADIOL IN KOMBINATION MIT DIENOGEST ZUR ORALEN THERAPIE FÜR DEN ERHALT UND/ODER STEIGERUNG DER WEIBLICHEN LIBIDO |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091954L true NO20091954L (no) | 2009-05-19 |
Family
ID=38809728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091954A NO20091954L (no) | 2006-10-20 | 2009-05-19 | Anvendelse av ostradiolvalerat eller 17ß-ostradil i kombinasjon med dienogest for oral terapi for opprettholdelse og/eller okning av kvinnelig libido |
Country Status (17)
Country | Link |
---|---|
US (1) | US8349820B2 (no) |
EP (2) | EP1930010A1 (no) |
JP (1) | JP2010506867A (no) |
KR (1) | KR20090080989A (no) |
AU (1) | AU2007312626A1 (no) |
BR (1) | BRPI0717462A2 (no) |
CA (1) | CA2666829C (no) |
CO (1) | CO6160297A2 (no) |
CR (1) | CR10732A (no) |
EA (1) | EA016631B1 (no) |
GT (1) | GT200900090A (no) |
IL (1) | IL198200A (no) |
MX (1) | MX2009004179A (no) |
NO (1) | NO20091954L (no) |
NZ (1) | NZ576336A (no) |
SV (1) | SV2009003231A (no) |
WO (1) | WO2008046559A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
US8153616B2 (en) * | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
US20070088011A1 (en) * | 2005-10-17 | 2007-04-19 | Susan Zeun | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4168068A (en) | 1969-07-22 | 1971-01-28 | Unisearch Limited | Improvements in or relating to oral contraceptives |
US3639600A (en) | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
US3795734A (en) | 1970-04-20 | 1974-03-05 | American Home Prod | Cyclic regimen of hormone administration for contraception |
US4066757A (en) | 1973-03-26 | 1978-01-03 | Ortho Pharmaceutical Corporation | Oral contraceptive regimen |
DE2365103C3 (de) | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
DE2431704A1 (de) | 1974-07-02 | 1976-01-22 | Asche Ag | Stufenkombinationspraeparate per kontrazeption |
DE2645307A1 (de) | 1976-10-05 | 1978-04-06 | Schering Ag | Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen |
NL8001593A (nl) | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4921843A (en) | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
US4616006A (en) | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4530839A (en) | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4544554A (en) | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4628051A (en) | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
DE3341638A1 (de) | 1983-11-17 | 1984-05-03 | Hermann Dr.rer.nat. 8000 München Heßlinger | Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol |
DE3347125A1 (de) | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
AU581486B2 (en) | 1985-12-30 | 1989-02-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
IE61236B1 (en) | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
CA2005933A1 (en) | 1989-01-09 | 1990-07-09 | Jesse Hipps, Sr. | Photohardenable composition containing five member aromatic group with imine moiety |
IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
DE4104385C1 (no) | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
DE4224534A1 (de) | 1992-07-24 | 1994-01-27 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel zur hormonalen Kontrazeption |
DE4308406C1 (de) | 1993-03-12 | 1994-06-16 | Jenapharm Gmbh | Kombinationspräparat zur Kontrazeption |
DE4313926A1 (de) | 1993-04-28 | 1994-11-03 | Jenapharm Gmbh | Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption |
DE4339934C2 (de) | 1993-05-07 | 1995-05-24 | Klaus Dr Med Umbreit | Ovulationshemmendes Mittel zur hormonalen Kontrazeption |
NL9301562A (nl) | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
DE4429374C1 (de) | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
DE19525017A1 (de) | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
US20050032756A1 (en) * | 1995-10-28 | 2005-02-10 | Michael Dittgen | Multistage preparation for contraception based on natural estrogens |
DE19540253C2 (de) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
JP2000515889A (ja) | 1996-07-26 | 2000-11-28 | アメリカン・ホーム・プロダクツ・コーポレイション | プロゲスチンとエストロゲンとの混合剤からなる二相性避妊法およびキット |
ATE271386T1 (de) | 1996-07-26 | 2004-08-15 | Wyeth Corp | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält |
WO1998004246A2 (en) | 1996-07-26 | 1998-02-05 | American Home Prod | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
US5858405A (en) | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
IL127923A (en) | 1996-07-26 | 2004-07-25 | Wyeth Corp | Pharmaceutical preparation swallowed to prevent pregnancy |
US6987101B1 (en) | 1996-12-20 | 2006-01-17 | Schering Aktiengesellschaft | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder |
DE19654609A1 (de) | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
DE19908762A1 (de) | 1999-02-18 | 2000-08-31 | Jenapharm Gmbh | Verwendung von Dienogest in hoher Dosierung |
DE10045380A1 (de) | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
US6699820B2 (en) | 2001-03-02 | 2004-03-02 | Hartmut Ulrich Bielefeldt | Method for making a superconductor with enhanced current carrying capability |
MXPA04002771A (es) | 2001-09-29 | 2004-06-29 | Solvay Pharm Gmbh | Preparacion combinada de estrogeno-gestageno y su uso. |
EP1462106A1 (en) | 2003-03-28 | 2004-09-29 | Pantarhei Bioscience B.V. | Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders |
WO2004112797A1 (en) | 2003-06-25 | 2004-12-29 | Schering Ag | Hormone replacement- and depression therapy comprising dienogest |
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
AR051931A1 (es) | 2004-10-07 | 2007-02-21 | Duramed Pharmaceuticals Inc | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes |
TW200726473A (en) | 2005-06-28 | 2007-07-16 | Wyeth Corp | Compositions and methods for treatment of cycle-related symptoms |
DK1787649T3 (da) | 2005-10-13 | 2009-06-02 | Bayer Schering Pharma Ag | Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
-
2007
- 2007-05-10 EP EP07009373A patent/EP1930010A1/de not_active Withdrawn
- 2007-10-12 KR KR1020097010244A patent/KR20090080989A/ko not_active Application Discontinuation
- 2007-10-12 JP JP2009532710A patent/JP2010506867A/ja active Pending
- 2007-10-12 WO PCT/EP2007/008866 patent/WO2008046559A1/de active Application Filing
- 2007-10-12 EA EA200900491A patent/EA016631B1/ru not_active IP Right Cessation
- 2007-10-12 CA CA2666829A patent/CA2666829C/en not_active Expired - Fee Related
- 2007-10-12 AU AU2007312626A patent/AU2007312626A1/en not_active Abandoned
- 2007-10-12 BR BRPI0717462-4A2A patent/BRPI0717462A2/pt not_active IP Right Cessation
- 2007-10-12 EP EP07818937A patent/EP2083827A1/de not_active Ceased
- 2007-10-12 MX MX2009004179A patent/MX2009004179A/es unknown
- 2007-10-12 NZ NZ576336A patent/NZ576336A/en not_active IP Right Cessation
- 2007-10-17 US US11/873,595 patent/US8349820B2/en not_active Expired - Fee Related
-
2009
- 2009-04-19 IL IL198200A patent/IL198200A/en not_active IP Right Cessation
- 2009-04-20 SV SV2009003231A patent/SV2009003231A/es unknown
- 2009-04-20 GT GT200900090A patent/GT200900090A/es unknown
- 2009-04-20 CR CR10732A patent/CR10732A/es not_active Application Discontinuation
- 2009-04-20 CO CO09039733A patent/CO6160297A2/es unknown
- 2009-05-19 NO NO20091954A patent/NO20091954L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008046559A1 (de) | 2008-04-24 |
CA2666829C (en) | 2012-02-07 |
US8349820B2 (en) | 2013-01-08 |
GT200900090A (es) | 2011-11-29 |
JP2010506867A (ja) | 2010-03-04 |
MX2009004179A (es) | 2009-04-30 |
NZ576336A (en) | 2012-03-30 |
IL198200A0 (en) | 2009-12-24 |
AU2007312626A1 (en) | 2008-04-24 |
IL198200A (en) | 2012-10-31 |
EP2083827A1 (de) | 2009-08-05 |
BRPI0717462A2 (pt) | 2013-12-24 |
EA016631B1 (ru) | 2012-06-29 |
SV2009003231A (es) | 2009-11-09 |
CA2666829A1 (en) | 2008-04-24 |
EA200900491A1 (ru) | 2009-10-30 |
CR10732A (es) | 2009-05-25 |
EP1930010A1 (de) | 2008-06-11 |
CO6160297A2 (es) | 2010-05-20 |
US20080125401A1 (en) | 2008-05-29 |
KR20090080989A (ko) | 2009-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091954L (no) | Anvendelse av ostradiolvalerat eller 17ß-ostradil i kombinasjon med dienogest for oral terapi for opprettholdelse og/eller okning av kvinnelig libido | |
MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
BRPI1007945B8 (pt) | formulação farmacêutica de liberação controlada de nitazoxamida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral | |
RS52831B (en) | THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY | |
MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
MX347237B (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. | |
CO6251259A2 (es) | Formulaciones farmaceuticas de estriol en baja dosis | |
HUP0402142A2 (hu) | Kombinációs ösztrogén-gestagen készítmény és alkalmazása | |
IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
MY152540A (en) | Powder formulation for valganciclovir | |
TW200738269A (en) | Oral delivery of therapeutic agents using tight junction agonists | |
HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
MX2009008813A (es) | Composicion farmaceutica que contiene floroglucinol y paracetamol. | |
CR10912A (es) | Preparacion framaceutica para reducir la endometriosis | |
EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
UA97960C2 (ru) | ПРИМЕНЕНИЕ ЭСТРАДИОЛА ВАЛЕРАТА ИЛИ 17β-ЭСТРАДИОЛА В КОМБИНАЦИИ С ДИЕНОГЕСТОМ ДЛЯ ПЕРОРАЛЬНОГО ЛЕЧЕНИЯ ДЛЯ ПОДДЕРЖАНИЯ И/ИЛИ ПОВЫШЕНИЯ ПОЛОВОГО ВЛЕЧЕНИЯ У ОСОБИ ЖЕНСКОГО ПОЛА | |
CU20090062A7 (es) | Uso de valerato de estradiol o 17beta-estradiol en combinación con dienogest en una terapia oral para mantener y/o incrementar la líbido femenina | |
PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
WO2009112232A3 (en) | New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen | |
DOP2009000079A (es) | Uso de valerato de estradiol en combinación con dienogest en una terapia oral para mantener y/o incrementar la líbido femenina | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
WO2009112231A3 (en) | Drospirenone/ 17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen | |
CU20090116A7 (es) | Preparación farmacéutica para reducir la endometriosis | |
UA33144U (ru) | Способ послеоперационной реабилитации больных с доброкачественной обтурационной желтухой | |
CL2009000608A1 (es) | Producto farmaceutico combinado trifasico con 24 unidades de dosificacion, en donde la cantidad de drospirenona de la primera a la tercera fase disminuye de 3 mg a 1,5 mg y la cantidad de 17 beta-estradiol aumenta de 1 mg a 2 mg, ademas de 4 unidades de dosificacion de placebo o sin unidades de dosificacion; kit farmaceutico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |